Observational retrospective study to describe the management of advanced epidermal growth factor receptor (EGFR) mutated (M+) non-small cell lung cancer (NSCLC) patients (pts) in Spain (NCT01795352).

Edurne Arriola,Ramón García Gómez,P. Diz,Margarita Majem,Maite Martínez Aguillo,J Valdivia,A. Paredes,José Miguel Sánchez Torres,Sergi Peralta,I. Barneto,Maria Carmen Gonzalez-Arenas

Observational retrospective study to describe the management of advanced epidermal growth factor receptor (EGFR) mutated (M+) non-small cell lung cancer (NSCLC) patients (pts) in Spain (NCT01795352).

2014

Edurne Arriola
Ramón García Gómez
P. Diz
Margarita Majem
Maite Martínez Aguillo
J Valdivia
A. Paredes
José Miguel Sánchez Torres
Sergi Peralta
I. Barneto
Maria Carmen Gonzalez-Arenas

e19133 Background: Activating mutations (mut) in EGFR gene confer sensitivity to the EGFR tyrosine kinase inhibitors (TKIs) in pts with advanced NSCLC improving progression free survival (PFS) rate...

Keywords:

non-small cell lung cancer (NSCLC)
Epidermal growth factor receptor
Pathology
Observational study
Cancer research
Retrospective cohort study
Medicine
Gene
Progression-free survival
EGFR Tyrosine Kinase Inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations